Midwest Trust’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$59.9M Buy
65,139
+1,518
+2% +$1.54M 0.75% 38
2025
Q4
$68.4M Buy
63,621
+13,464
+27% +$12.9M 0.85% 26
2025
Q3
$38.3M Buy
50,157
+920
+2% +$685K 0.5% 51
2025
Q2
$38.4M Buy
+49,237
New +$38.3M 0.53% 47

Other funds holding LLY

Midwest Trust's LLY Position: Q1 2026 in Review

Midwest Trust increased its Eli Lilly (LLY) stake by 2.4% in Q1 2026, buying an estimated $1.54M and bringing the position to 65,139 shares worth $59.9M. The position accounts for 0.75% of the portfolio, ranked #38.

Midwest Trust first reported a position in LLY in Q2 2025 and has held it in 4 quarters since. The position peaked at $68.4M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Midwest Trust held 65,139 shares of Eli Lilly worth $59.9M as of Q1 2026.
  • Midwest Trust bought 1,518 Eli Lilly shares in Q1 2026, an estimated $1.54M.
  • Eli Lilly made up 0.75% of Midwest Trust's portfolio in Q1 2026, its #38 holding.
  • Midwest Trust first reported a position in Eli Lilly in Q2 2025 and has held it in 4 quarters since.
  • Midwest Trust's Eli Lilly position peaked at $68.4M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Midwest Trust's 13F filing for Q1 2026, filed 1 May 2026.